Trending: Explosion at Enel's Italian Hydro Plant
1103 GMT - Enel is among the most mentioned companies across news items over the past five hours, according to Factiva data, after an explosion at a hydroelectric power plant owned by the Rome-based energy group killed at least three people. A spokesman for the Italian fire brigade said five people were also injured and four are still missing and that the explosion was likely caused by a fire in a turbine or a transformer at the plant. "We do not expect a significant financial impact beyond the unavailability of the power plant," Capital Markets Equity Research analysts say in a note. However Equita analysts say "it is difficult to quantify the potential economic damages for Enel considering insurance coverage and the potential operation of one of the two units, as well as the repair time of the plant itself with the turbine replacement." Shares fall 0.1% to EUR5.82. Dow Jones & Co. owns Factiva. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
April 10, 2024 07:18 ET (11:18 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track